Association of transforming growth factor-1 gene C-509T and T869C polymorphisms with atherosclerotic cerebral infarction in the Chinese: A case-control study

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Peng, Zhongxing ^a,b   Zhan, Lixuan ^a   Chen, Shengqiang ^a   Xu, En ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TGFB1 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; ATHEROSCLEROTIC CEREBRAL INFARCTION; BRAIN ATHEROSCLEROSIS; BRAIN INFARCTION; CASE CONTROL STUDY; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; ASIAN; ATHEROSCLEROSIS; BLOOD; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; BASE SEQUENCE; CASE-CONTROL STUDIES; CEREBRAL INFARCTION; CHOLESTEROL; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA1; TRIGLYCERIDES;

EID: 79959284753     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-100     Document Type: Article

References (40)

1. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. E Flossmann UG Schulz PM Rothwell, Stroke 2004 35 212 227 14684773 (Pubitemid 38057622)
2. Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease. S Rubattu M Volpe R Kreutz U Ganten D Ganten K Lindpaintner, Nat Genet 1996 13 429 434 10.1038/ng0896-429 8696337 (Pubitemid 26256616)
3. Genetics of ischemic stroke. M Dichigans, Lancet Neurol 2007 6 149 161 10.1016/S1474-4422(07)70028-5 17239802
4. Endothelial nitric oxide synthase exon7 polymorphism, ischemic cerebrovascular disease, and carotid atheroma. HS Markus Y Ruigrok N Ali JF Powell, Stroke 1998 29 1908 1911 10.1161/01.STR.29.9.1908 9731617 (Pubitemid 28399986)
5. Angiotensin-converting enzyme insertion/deletion polymorphism and the risk of ischemic stroke in a South Indian population. A Munshi S Sultana S Kaul B Pulla Reddy S Alladi A Jyothy, J Neurol Sci 2008 272 132 135 10.1016/j.jns.2008.05.017 18586276
6. Polymorphisms of the lipoprotein lipase gene are associated with atherosclerotic cerebral infarction in the Chinese. E Xu W Li L Zhan G Guan X Wang S Chen Y Shi, Neuroscience 2008 155 403 408 10.1016/j.neuroscience.2008.06. 007 18590804
7. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. G Stoll M Bendszus, Stroke 2006 37 1923 1932 10.1161/01.STR.0000226901.34927.10 16741184 (Pubitemid 44297753)
8. Inflammatory gene polymorphisms and ischemic heart disease: review of population association studies. F Andreotti I Porto F Crea A Maseri, Heart 2002 87 107 112 10.1136/heart.87.2.107 11796541 (Pubitemid 34098367)
9. Role of transforming growth factor beta in human disease. GC Blobe WP Schiemann HF Lodish, N Engl J Med 2000 342 1350 1358 10.1056/NEJM200005043421807 10793168 (Pubitemid 30408720)
10. Transforming growth factor-beta, cell signaling and cardiovascular disorders. A Agrotis N Kalinina A Bobik, Curr Vasc Pharmacol 2005 3 55 61 10.2174/1570161052773951 15638782 (Pubitemid 40089527)
11. Expression of transforming growth factor-beta1 is increased in human vascular restenosis lesions. S Nikol JM Isner JG Pickering M Kearney G Leclerc L Weir, J Clin Invest 1992 90 1582 1592 10.1172/JCI116027 1328302
12. Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. F Cipollone M Fazia G Mincione A Iezzi B Pini C Cuccurullo S Ucchino F Spigonardo M Di Nisio F Cuccurullo A Mezzetti E Porreca, Stroke 2004 35 2253 2257 10.1161/01.STR.0000140739.45472.9c 15297631 (Pubitemid 39311245)
13. Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. AK Robertson M Rudling X Zhou L Gorelik RA Flavell GK Hansson, J Clin Invest 2003 112 1342 1350 14568988 (Pubitemid 38057688)
14. Prognostic significance of plasma concentrations of transforming growth factor-beta in patients with coronary artery disease. H Tashiro H Shimokawa K Sadamatu K Yamamoto, Coron Artery Dis 2002 13 139 143 10.1097/00019501- 200205000-00001 12131016 (Pubitemid 34747960)
15. In vivo effect of TGF-beta 1. Enhanced intimal thickening by administration of TGF- beta 1 in rabbit arteries injured with a balloon catheter. T Kanzaki K Tamura K Takahashi Y Saito B Akikusa H Oohashi N Kasayuki M Ueda N Morisaki, Arterioscler Thromb Vasc Biol 1995 15 1951 1957 10.1161/01.ATV.15.11.1951 7583576
16. Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. AH Schulick AJ Taylor W Zuo CB Qiu G Dong RN Woodward R Agah AB Roberts R Virmani DA Dichek, Proc Natl Acad Sci USA 1998 95 6983 6988 10.1073/pnas.95.12.6983 9618525 (Pubitemid 28278093)
17. Transforming growth factor-beta: biology and clinical relevance. IY Kim MM Kim SJ Kim, J Biochem Mol Biol 2005 38 1 8 15715939 (Pubitemid 43025971)
18. TGF-beta signaling and the fibrotic response. A Leask DJ Abraham, FASEB J 2004 18 816 827 10.1096/fj.03-1273rev 15117886
19. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. MR Awad A El-Gamel P Hasleton DM Turner PJ Sinnott IV Hutchinson, Transplantation 1998 66 1014 1020 10.1097/00007890-199810270-00009 9808485 (Pubitemid 28513380)
20. Genetic control of the circulating concentration of transforming growth factor type beta1. DJ Grainger K Heathcote M Chiano H Snieder PR Kemp JC Metcalfe ND Carter TD Spector, Hum Mol Genet 1999 8 93 97 10.1093/hmg/8.1.93 9887336 (Pubitemid 29039053)
21. Allelic diversity in the TGF1 regulatory region: characterization of novel functional single nucleotide polymorphisms. R Shah B Rahaman CK Hurley PE Posch, Hum Genet 2006 119 61 74 10.1007/s00439-005-0112-y 16369764
22. Association of a T29C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. M Yokota S Ichihara TL Lin N Nakashima Y Yamada, Circulation 2000 101 2783 2787 10859282 (Pubitemid 30396007)
23. A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. AM Dunning PD Ellis S McBride HL Kirschenlohr CS Healey PR Kemp RN Luben J Chang-Claude A Mannermaa V Kataja PD Pharoah DF Easton BA Ponder JC Metcalfe, Cancer Res 2003 63 2610 2615 12750287 (Pubitemid 36605203)
24. Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma. ES Silverman LJ Palmer V Subramaniam A Hallock S Mathew J Vallone DS Faffe T Shikanai BA Raby ST Weiss SA Shore, Am J Respir Crit Care Med 2004 169 214 219 14597484 (Pubitemid 38114537)
25. Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. M Suthanthiran B Li JO Song R Ding VK Sharma JE Schwartz P August, Proc Natl Acad Sci USA 2000 97 3479 3484 10.1073/pnas.050420897 10725360 (Pubitemid 30183328)
26. Oestrogen receptor alpha gene polymorphism is related to aortic valve sclerosis in postmenopausal women. P Nordström CA Glader G Dahlén LS Birgander R Lorentzon A Waldenström M Lorentzon, J Intern Med 2003 254 140 146 10.1046/j.1365-2796.2003.01179.x 12859695 (Pubitemid 36900437)
27. Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease. W Koch P Hoppmann JC Mueller A Schömig A Kastrati, Arterioscler Thromb Vasc Biol 2006 26 1114 1119 10.1161/01.ATV.0000217747.66517.11 16543493 (Pubitemid 43732120)
28. Role of TGF-beta1 haplotypes in the occurrence of myocardial infarction in young Italian patients. F Crobu L Palumbo E Franco S Bergerone S Carturan S Guarrera S Frea G Trevi A Piazza G Matullo, BMC Med Genet 2008 9 13 18312614
29. TGF-beta 1 polymorphisms and risk of myocardial infarction and stroke: the Rotterdam Study. MP Sie AG Uitterlinden MJ Bos PP Arp MM Breteler PJ Koudstaal HA Pols A Hofman CM van Duijn JC Witteman, Stroke 2006 37 2667 2671 10.1161/01.STR.0000244779.30070.1a 17023672 (Pubitemid 44922523)
30. Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients. B Altun R Yilmaz S Kahraman G Gençtoy M Arici O Onalan A Oto M Hayran M Bakkalolu U Yasavul C Turgan, Transpl Int 2005 18 681 689 10.1111/j.1432-2277.2005.00118.x 15910294 (Pubitemid 41726833)
31. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. P Syrris ND Carter JC Metcalfe PR Kemp DJ Grainger JC Kaski DC Crossman SE Francis J Gunn S Jeffery K Heathcote, Clin Sci 1998 95 659 667 9831690 (Pubitemid 29034430)
32. A common polymorphism of the transforming growth factor-beta1 gene and coronary artery disease. XL Wang AS Sim DE Wilcken, Clin Sci 1998 95 745 746 10.1042/CS19980292 9831700 (Pubitemid 29034440)
33. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Z Mallat A Gojova C Marchiol-Fournigault B Esposito C Kamate R Merval D Fradelizi A Tedgui, Circ Res 2001 89 930 934 10.1161/hh2201.099415 11701621 (Pubitemid 34627899)
34. -5 polymorphisms in the transforming growth factor-beta 1 gene (TGF-beta 1) in adult periodontitis. LI Holla A Fassmann P Benes T Halabala V Znojil, J Clin Periodontol 2002 29 336 341 10.1034/j.1600-051X.2002.290409.x 11966931 (Pubitemid 41697845)
35. Chloesterol suppresses cellular TGF- responsiveness: implications in atherogenesis. CL Chen IH Liu SJ Fliesler XL Han SS Huang JS Huang, J Cell Sci 2007 120 3509 3521 10.1242/jcs.006916 17878231 (Pubitemid 350120944)
36. Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases. K Oda N Tanaka T Arai J Araki Y Song L Zhang A Kuchiba T Hosoi T Shirasawa M Muramatsu M Sawabe, Hum Mol Genet 2007 16 592 599 17213232 (Pubitemid 46585661)
37. Genetic analysis of protein export in Escherishia coli K12. SA Benson MN Hall TJ Silhavy, Annu Rev Biochem 1985 54 101 134 10.1146/annurev.bi.54.070185. 000533 3896116 (Pubitemid 15073643)
38. Transforming growth factor-beta up-regulates low density lipoprotein receptor-mediated cholesterol metabolism in vascular smooth muscle cells. AC Nicholson DP Hajjar, J Biol Chem 1992 267 25982 25987 1464611 (Pubitemid 23014005)
39. A critical role for the Sp1-binding sites in the transforming growth factor-beta-mediated inhibition of lipoprotein lipase gene expression in macrophages. SA Irvine P Foka SA Rogers JR Mead DP Ramji, Nucleic Acids Res 2005 33 1423 1434 10.1093/nar/gki280 15755745 (Pubitemid 41418372)
40. How many diseases does it take to map a gene with SNPs? KM Weiss JD Terwilliger, Nat Genet 2000 26 151 157 10.1038/79866 11017069